Augustine Therapeutics will be participating in the 24th Bio-Equity Europe

12.04.2024

Augustine Therapeutics will be participating in the 24th Bio Equity Europe on May 12-14, 2024 in San Sebastián, Spain, as well as during May 21-22 virtual partnering days.

Our CEO, Dr. Sylvain Celanire, and Chairman, Dr. Gerhard Koenig will be available for one-on-one meetings throughout the conference, to share the progress of our unique assets targeting HDAC6 inhibition for the potential treatment of PNS, CNS and cardio-metabolism diseases.

Please reach out through the conference online partnering system.

Look for more information: Bio€quity Europe 2024

05/09/2022 Event

Augustine Therapeutics is proud to announce as one of the Sponsors and Participants of the 2022 Global CMT Research Convention

19/10/2022 Event

Augustine Therapeutics’ leadership team will be attending and presenting at two major conferences in London, UK

03/04/2023 Event

Augustine Tx Participating in the 23rd Bio€quity Europe in May

All news articles

A thinline.be | soon production

Wijzig uw cookie voorkeuren

Augustine Therapeutics is proud to announce as one of the Sponsors and Participants of the 2022 Global CMT Research Convention

Augustine Therapeutics’ leadership team will be attending and presenting at two major conferences in London, UK

Augustine Tx Participating in the 23rd Bio€quity Europe in May